Cargando…

IgA binds to the AD‐2 epitope of glycoprotein B and neutralizes human cytomegalovirus

Human cytomegalovirus (HCMV) is a ubiquitous pathogen that is potentially pathogenic in immunosuppressed individuals and pregnant females during primary infection. The HCMV envelope glycoprotein B (gB) facilitates viral entry into all cell types and induces a potent immune response. AD‐2 epitope is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siddiqui, Saima, Hackl, Sarah, Ghoddusi, Hamid, McIntosh, Megan R., Gomes, Ariane C., Ho, Joshua, Reeves, Matthew B., McLean, Gary R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884650/ https://www.ncbi.nlm.nih.gov/pubmed/33283275 http://dx.doi.org/10.1111/imm.13286

Ejemplares similares

A temperature-dependent virus-binding assay reveals the presence of neutralizing antibodies in human cytomegalovirus gB vaccine recipients’ sera
por: Gomes, Ariane C., et al.
Publicado: (2023)

Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia
por: Baraniak, Ilona, et al.
Publicado: (2018)

Polymorphic Forms of Human Cytomegalovirus Glycoprotein O Protect against Neutralization of Fibroblast Entry by Antibodies Targeting Epitopes Defined by Glycoproteins H and L
por: He, Li, et al.
Publicado: (2022)

Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller
por: Lorin, Valérie, et al.
Publicado: (2022)

Total IgA and IgA reactivity to antigen I/II epitopes in HLA-DRB1*04 positive subjects
por: McCarlie, V. Wallace, et al.
Publicado: (2013)

Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG
Publicado: (1985)

Systemic administration of an HIV 1 broadly neutralizing dimeric IgA yields mucosal secretory IgA and virus neutralization
por: Fouda, Genevieve G., et al.
Publicado: (2016)

A fully human neutralizing monoclonal antibody targeting a highly conserved epitope of the human cytomegalovirus glycoprotein B
por: Okamoto, Miwa, et al.
Publicado: (2023)

Galectin-8 in IgA Nephritis: Decreased Binding of IgA by Galectin-8 Affinity Chromatography and Associated Increased Binding in Non-IgA Serum Glycoproteins
por: Carlsson, Michael C., et al.
Publicado: (2011)

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
por: Bootz, Anna, et al.
Publicado: (2017)

Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein
por: Gandolfo, Claudia, et al.
Publicado: (2021)

Similar Epitope Specificities of IgG and IgA Antibodies Elicited by Ad26 Vector Prime, Env Protein Boost Immunizations in Rhesus Monkeys
por: Kang, Zi Han, et al.
Publicado: (2018)

Purpura-free small intestinal IgA vasculitis complicated by cytomegalovirus reactivation
por: Matsumura, Mariko, et al.
Publicado: (2020)

Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome
por: Pericleous, Charis, et al.
Publicado: (2016)

Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
por: Kropff, Barbara, et al.
Publicado: (2012)

Neutralization Epitopes in Trimer and Pentamer Complexes Recognized by Potent Cytomegalovirus-Neutralizing Human Monoclonal Antibodies
por: Ai, Yuanbao, et al.
Publicado: (2022)

Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2
por: Klingler, Jéromine, et al.
Publicado: (2020)

Galactose-Deficient IgA1-Specific Antibody Recognizes GalNAc-Modified Unique Epitope on Hinge Region of IgA1
por: Yamasaki, Kohei, et al.
Publicado: (2018)

The generation and evaluation of two panels of epitope-matched mouse IgG1, IgG2a, IgG2b and IgG3 antibodies specific for Plasmodium falciparum and Plasmodium yoelii merozoite surface protein 1–19 (MSP1(19))
por: Adame-Gallegos, Jaime R., et al.
Publicado: (2012)

Human cytomegalovirus and transplantation: drug development and regulatory issues
por: McIntosh, Megan, et al.
Publicado: (2016)

Enhanced SARS-CoV-2 neutralization by dimeric IgA
por: Wang, Zijun, et al.
Publicado: (2021)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes
por: Shibamura, Miho, et al.
Publicado: (2020)

Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein
por: Kam, Yiu-Wing, et al.
Publicado: (2012)

IgA, albumin, and eosinopenia as early indicators of cytomegalovirus infection in patients with acute ulcerative colitis
por: Yang, Hong, et al.
Publicado: (2020)

Cytomegalovirus colitis unmasking human immunodeficiency virus infection as a cause of IgA vasculitis
por: Bartoletti, Alice, et al.
Publicado: (2023)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Src family kinase activity drives cytomegalovirus reactivation by recruiting MOZ histone acetyltransferase activity to the viral promoter
por: Dupont, Liane, et al.
Publicado: (2019)

Localization of major neutralizing epitopes on the S1 polypeptide of the murine coronavirus peplomer glycoprotein
por: Sayaka, Takase-Yoden, et al.
Publicado: (1991)

Localization of the virus neutralizing and hemagglutinin epitopes of E1 glycoprotein of rubella virus
por: Chaye, Helena, et al.
Publicado: (1992)

In Silico Analysis of Neutralizing Antibody Epitopes on The Hepatitis C Virus Surface Glycoproteins
por: Zareh-Khoshchehreh, Raziyeh, et al.
Publicado: (2023)

Production of Hybrid-IgG/IgA Plantibodies with Neutralizing Activity against Shiga Toxin 1
por: Nakanishi, Katsuhiro, et al.
Publicado: (2013)

Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro
por: Wang, Zijun, et al.
Publicado: (2020)

Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
por: Spindler, Nadja, et al.
Publicado: (2014)

Tripterygium Wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathy
por: Li, Huining, et al.
Publicado: (2017)

IgA Staining Patterns Differentiate Between IgA Nephropathy and IgA-Dominant Infection-Associated Glomerulonephritis
por: Brodsky, Sergey V., et al.
Publicado: (2020)

IgA is the predominant isotype of anti‐β2 glycoprotein I antibodies in rheumatoid arthritis
por: Melayah, Sarra, et al.
Publicado: (2020)

Increased Urinary IgA in Paediatric IgA Vasculitis Nephritis
por: Marro, Julien, et al.
Publicado: (2022)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Correlation between the IgG/IgA Antibody Response against PEDV Structural Protein and Virus Neutralization
por: Song, Xu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_17h0thoat6oltnucfuvg6vlg64